Chemours Market Sentiment

SPY769.22−1.13%QQQ727.89−2.11%BTC/USD81,618.80−1.78%DIA515.25−0.19%GLD376.15−1.45%TLT78.82+0.57%

Premium

The Chemours Co

CCNYSE

Trade with Public

$12.86

-0.34-2.61%

Last update: Oct 14, 3:59 PM

$12.75

-0.45-3.41%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Dividends Compare Options Stock Report

Chemours Market Sentiment - Benzinga

Chemours Market Sentiment

Market sentiment signals for Chemours (CC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▲ 14.3% short float

Options Flow▼ 2.29 P/C ratio

Insider Activity— N/A

Analyst Consensus

Neutral

10 analysts

Options Flow (P/C)

2.29

More puts — Bearish

399 calls · 915 puts

Avg Consensus PT

$18

+38.4%

Highest Price Target

$24

+86.6%

Truist Securities

Lowest Price Target

$13

+1.1%

Barclays

Short Interest

14.3%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 14, 2026	Mizuho	John Roberts—	+16.6%	$18 → $15	Downgrade	Outperform→Neutral
Oct 13, 2026	Barclays	Aleksey Yefremov—	+24.4%	$16	Initiate	Equal-Weight
Oct 5, 2026	UBS	Joshua Spector—	+24.4%	$18 → $16	Maintained	Neutral
Sep 30, 2026	Mizuho	John Roberts—	+40.0%	$20 → $18	Maintained	Outperform
Aug 13, 2026	JP Morgan	Jeffrey Zekauskas—	+16.6%	$22 → $15	Maintained	Neutral
Aug 13, 2026	BMO Capital	John McNulty—	+40.0%	$26 → $18	Maintained	Outperform
Aug 10, 2026	UBS	Joshua Spector—	+40.0%	$29 → $18	Downgrade	Buy→Neutral
Aug 6, 2026	RBC Capital	Arun Viswanathan—	+71.1%	$26 → $22	Maintained	Outperform
Aug 6, 2026	Truist Securities	Peter Osterland—	+86.6%	$30 → $24	Maintained	Buy
Jul 1, 2026	Mizuho	John Roberts—	+94.4%	$30 → $25	Maintained	Outperform
May 21, 2026	JP Morgan	Jeffrey Zekauskas—	+71.1%	$17 → $22	Maintained	Neutral
May 11, 2026	Morgan Stanley	Vincent Andrews—	+63.3%	$17 → $21	Maintained	Equal-Weight
May 11, 2026	RBC Capital	Arun Viswanathan—	+125.5%	$26 → $29	Maintained	Outperform
May 8, 2026	UBS	Joshua Spector—	+133.3%	$29 → $30	Maintained	Buy
Apr 28, 2026	Truist Securities	Peter Osterland—	+133.3%	$27 → $30	Maintained	Buy
Apr 9, 2026	UBS	Joshua Spector—	+125.5%	$23 → $29	Maintained	Buy
Apr 9, 2026	Truist Securities	Peter Osterland—	+110.0%	$21 → $27	Maintained	Buy
Mar 5, 2026	Mizuho	John Roberts—	+63.3%	$17 → $21	Maintained	Outperform
Feb 25, 2026	Goldman Sachs	Duffy Fischer—	+40.0%	$14 → $18	Maintained	Neutral
Feb 23, 2026	UBS	Joshua Spector—	+78.8%	$18 → $23	Maintained	Buy
Feb 23, 2026	BMO Capital	John McNulty—	+47.7%	$20 → $19	Maintained	Outperform
Feb 23, 2026	JP Morgan	Jeffrey Zekauskas—	+32.2%	$13 → $17	Maintained	Neutral
Feb 23, 2026	Morgan Stanley	Vincent Andrews—	+32.2%	$15 → $17	Maintained	Equal-Weight
Jan 21, 2026	Truist Securities	Peter Osterland—	+63.3%	$18 → $21	Maintained	Buy
Dec 3, 2025	JP Morgan	Jeffrey Zekauskas—	+1.1%	$15 → $13	Maintained	Neutral

More with Benzinga EdgeGet Access

Insider & Market Activity News

PRO
Chemours Company Form4 Filing Shows President and CEO Mark Newman Bought 7,661 Shares At An Average Price Of $34.63/Share

- SEC Filing

Benzinga Newsdesk

Stocks That Hit 52-Week Lows On Tuesday

Tuesday's session saw 729 companies set new 52-week lows.

Benzinga Insights

Chemours Option Alert: Jun 19 $18 Calls Sweep (3) near the Ask: 450 @ $0.35 vs 12 OI; Earnings 7/30 After Close [est] Ref=$16.5568

Charles Gross

Chemours Option Alert: Feb 21 $18 Calls Sweep (44) near the Ask: 1050 @ $0.2 vs 1510 OI; Earnings 2/13 After Close Ref=$14.6982

Charles Gross

Chemours Option Alert: Jan 17 $14 Puts Sweep (13) near the Ask: 699 @ $1.243 vs 16198 OI; Ref=$14.48

Charles Gross

Chemours Option Alert: Oct 18 $25 Calls Sweep (2) near the Ask: 1000 @ $0.95 vs 1707 OI; Earnings 8/1 After Close [est] Ref=$21.29

Charles Gross

The Chemours Co

Chemours Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

PRO
Chemours Company Form4 Filing Shows President and CEO Mark Newman Bought 7,661 Shares At An Average Price Of $34.63/Share

Stocks That Hit 52-Week Lows On Tuesday

Chemours Option Alert: Jun 19 $18 Calls Sweep (3) near the Ask: 450 @ $0.35 vs 12 OI; Earnings 7/30 After Close [est] Ref=$16.5568

Chemours Option Alert: Feb 21 $18 Calls Sweep (44) near the Ask: 1050 @ $0.2 vs 1510 OI; Earnings 2/13 After Close Ref=$14.6982

Chemours Option Alert: Jan 17 $14 Puts Sweep (13) near the Ask: 699 @ $1.243 vs 16198 OI; Ref=$14.48

Chemours Option Alert: Oct 18 $25 Calls Sweep (2) near the Ask: 1000 @ $0.95 vs 1707 OI; Earnings 8/1 After Close [est] Ref=$21.29

People Also Watch

Bulls vs Bears

People Also Watch

The Chemours Co

Chemours Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

PROChemours Company Form4 Filing Shows President and CEO Mark Newman Bought 7,661 Shares At An Average Price Of $34.63/Share

Stocks That Hit 52-Week Lows On Tuesday

Chemours Option Alert: Jun 19 $18 Calls Sweep (3) near the Ask: 450 @ $0.35 vs 12 OI; Earnings 7/30 After Close [est] Ref=$16.5568

Chemours Option Alert: Feb 21 $18 Calls Sweep (44) near the Ask: 1050 @ $0.2 vs 1510 OI; Earnings 2/13 After Close Ref=$14.6982

Chemours Option Alert: Jan 17 $14 Puts Sweep (13) near the Ask: 699 @ $1.243 vs 16198 OI; Ref=$14.48

Chemours Option Alert: Oct 18 $25 Calls Sweep (2) near the Ask: 1000 @ $0.95 vs 1707 OI; Earnings 8/1 After Close [est] Ref=$21.29

People Also Watch

Bulls vs Bears

People Also Watch

PRO
Chemours Company Form4 Filing Shows President and CEO Mark Newman Bought 7,661 Shares At An Average Price Of $34.63/Share